258 related articles for article (PubMed ID: 12116753)
1. New treatment options for overactive bladder and incontinence.
Newman DK
Director; 2002; 10(3):74-6. PubMed ID: 12116753
[No Abstract] [Full Text] [Related]
2. Achieving bladder control. Treatment in the primary care setting.
Maloney CM; Cafiero M
Adv Nurse Pract; 2002 May; 10(5):73-8. PubMed ID: 12420535
[No Abstract] [Full Text] [Related]
3. Overactive bladder. Strategies for better recognition and management.
Smith DA
Adv Nurse Pract; 2004 Mar; 12(3):26-33; quiz 34. PubMed ID: 15038182
[No Abstract] [Full Text] [Related]
4. Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
Hartnett NM; Saver BG
J Fam Pract; 2001 Jul; 50(7):571. PubMed ID: 11485700
[No Abstract] [Full Text] [Related]
5. Contemporary treatment options for overactive bladder.
Taylor PH; Sussman DO
JAAPA; 2005 Nov; Suppl():3-13; quiz 14-5. PubMed ID: 16315503
[No Abstract] [Full Text] [Related]
6. Treatments for overactive bladder.
Newton M; Kosier JH; Smith D
Urol Nurs; 2000 Aug; 20(4):267-8. PubMed ID: 11998091
[No Abstract] [Full Text] [Related]
7. Anticholinergic drugs for overactive bladder.
Kripke C
Am Fam Physician; 2006 Jan; 73(1):66. PubMed ID: 16417066
[No Abstract] [Full Text] [Related]
8. Detrol LA and Diropan XL for overactive bladder.
Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473
[No Abstract] [Full Text] [Related]
9. Medical treatment of overactive bladder.
Rackley R; Wein A; Nelson D
Mayo Clin Proc; 2001 Nov; 76(11):1179-80. PubMed ID: 11702910
[No Abstract] [Full Text] [Related]
10. Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial.
Appell RA
Curr Urol Rep; 2002 Oct; 3(5):343-4. PubMed ID: 12354340
[No Abstract] [Full Text] [Related]
11. Medication update.
Slagle M
South Med J; 2002 Feb; 95(2):188-91. PubMed ID: 11846243
[No Abstract] [Full Text] [Related]
12. Assessment and management of urinary incontinence.
Gray M
Nurse Pract; 2005 Jul; 30(7):32-3, 36-43; quiz 43-5. PubMed ID: 16021028
[No Abstract] [Full Text] [Related]
13. The overactive bladder: a nursing perspective.
Newman DK; Giovannini D
Am J Nurs; 2002 Jun; 102(6):36-45; quiz 46. PubMed ID: 12394076
[TBL] [Abstract][Full Text] [Related]
14. Editorial comment.
de Jong TP
J Urol; 2009 Oct; 182(4 Suppl):2038; discussion 2039. PubMed ID: 19695627
[No Abstract] [Full Text] [Related]
15. Editorial comment.
Jorgensen TM
J Urol; 2009 Oct; 182(4 Suppl):2038; discussion 2039. PubMed ID: 19695626
[No Abstract] [Full Text] [Related]
16. Editorial comment.
Yang SS
J Urol; 2009 Oct; 182(4 Suppl):2038-9; discussion 2039. PubMed ID: 19695625
[No Abstract] [Full Text] [Related]
17. Tolterodine.
Nurs Times; 2006 Jun 6-12; 102(23):27. PubMed ID: 16784047
[No Abstract] [Full Text] [Related]
18. [Urinary incontinence--treatment].
Hader C; Welz-Barth A; Keller T
Dtsch Med Wochenschr; 2003 Apr; 128(14):750-2. PubMed ID: 12673531
[No Abstract] [Full Text] [Related]
19. Pharmacologic treatment for detrusor overactivity.
Lai HH; Boone TB; Appell RA
Curr Urol Rep; 2002 Oct; 3(5):365-72. PubMed ID: 12354344
[TBL] [Abstract][Full Text] [Related]
20. Costs and resources associated with the treatment of overactive bladder using retrospective medical care claims data.
Hall JA; Nelson MA; Meyer JW; Williamson T; Wagner S
Manag Care Interface; 2001 Aug; 14(8):69-75. PubMed ID: 11517841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
